FSD Pharma Inc. | WebDisclosure

Basculer en Français

10165	Companies
208911	Keywords
138977	Articles
110714	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 02/26/2024 at 14:00, 2 years 1 month ago

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication

FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF

published on 02/26/2024 at 14:00, 2 years 1 month ago

FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™

FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRIEF

published on 02/26/2024 at 14:00, 2 years 1 month ago

FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™

FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
PRESS RELEASE

published on 02/17/2024 at 01:10, 2 years 1 month ago

FSD Pharma Announces US ATM Offering
FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes

FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE

published on 02/06/2024 at 13:00, 2 years 2 months ago

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania

FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE

published on 01/29/2024 at 22:30, 2 years 2 months ago

FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets

FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE

published on 01/16/2024 at 13:30, 2 years 2 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics.

Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE

published on 12/23/2023 at 01:45, 2 years 3 months ago

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE

published on 12/05/2023 at 15:00, 2 years 4 months ago

FSD Pharma Inc. Announces Closing of Private Placement
FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes

Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE

published on 11/30/2023 at 14:30, 2 years 4 months ago

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders

FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities

Accesswire

Published on 04/07/2026 at 09:30, 1 hour 45 minutes ago

Formation Metals to Host Live Investor Webinar on the N2 Gold Project to Discuss Phase 1 Drill Results, including 1.75 g/t Au over 30.4 Metres, and Maiden Resource Estimate Following Fully Funded 30,000-Metre Program
Published on 04/07/2026 at 09:05, 2 hours 10 minutes ago

BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
Published on 04/07/2026 at 09:01, 2 hours 14 minutes ago

Apex Drills 81.6 m of 2.02% REO, including 50.9 m of 2.40% REO, Extending Strike Length of Main Body, with Highly Enriched NdPr Zone at Rift
Published on 04/07/2026 at 08:00, 3 hours 15 minutes ago

Caledonia Mining Corporation Plc: Encouraging Results From Deep Level Drilling at Blanket Mine
Published on 04/07/2026 at 00:02, 11 hours 13 minutes ago

Evergold Announces Closing of $5.4 Million Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 04/07/2026 at 11:06, 9 minutes ago

TenneT Germany completes inaugural ratings process and prepares for debt capital market debut
Published on 04/07/2026 at 10:58, 17 minutes ago

Original-Research: Daldrup & Söhne (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 10:05, 1 hour 10 minutes ago

Ye celebrates his birthday on June 8 with a show at GelreDome; free bus transport arranged for fans from Germany
Published on 04/07/2026 at 10:00, 1 hour 15 minutes ago

Les dix ans de Swiss Prime Fondation de placement – un exercice 2025 couronné de succès
Published on 04/07/2026 at 09:13, 2 hours 2 minutes ago

Apprenticeship 2026: Entry-level salaries reflect economic change

Les Echos

Published on 04/07/2026 at 08:30, 2 hours 45 minutes ago

Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:30, 2 hours 45 minutes ago

Edenred obtient la note « A » au CDP et rejoint les leaders mondiaux engagés pour le climat
Published on 04/07/2026 at 08:00, 3 hours 15 minutes ago

Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
Published on 04/07/2026 at 08:00, 3 hours 15 minutes ago

Un pacte mondial annoncé lors du G7 One Health Summit pour accélérer l'accès aux diagnostics face aux menaces sanitaires croissantes
Published on 04/06/2026 at 15:00, 20 hours 15 minutes ago

FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality

View all LES ECHOS COMFI WIRE